Boost your income with these ASX dividend shares: experts

If you’re looking for dividend shares to boost your income, then you may want to check out the two listed below.

Here’s why these ASX dividend shares have been rated as buys:

Centuria Industrial REIT (ASX: CIP)

The first ASX dividend share to look at is Centuria Industrial.

It is the largest domestic pure play industrial REIT on the Australian share market and the owner of a high quality portfolio of in-demand properties.

Demand has been so strong that last month the company revealed that its occupancy rate increased to ~99% with a weighted average lease expiry of 8.3 years. This helped underpin a 22% increase in funds from operations to $111.7 million.

Analysts at Macquarie were pleased with its performance and appear confident on its outlook. The broker currently has an outperform rating and $3.69 price target on its shares.

As for dividends, Macquarie is expecting dividends per share of approximately 16 cents in FY 2023 and FY 2024. Based on the current Centuria Industrial share price of $2.70, this will mean yields of 5.9% for investors.

Medibank Private Ltd (ASX: MPL)

Another ASX dividend share that has been tipped as a buy is Medibank.

It is of course one of Australia’s leading private health insurers, operating the Medibank and AHM brands.

The team at Citi is positive on the private health insurer and recently put a buy rating and $4.00 price target on its shares.

Citi was pleased with Medibank’s full year results and expects more of the same in the coming years. Particularly given its positive exposure to higher interest rates.

In light of this, the broker is expecting Medibank’s shares to provide attractive yields in the near term. It is forecasting fully franked dividends of 15.9 cents per share in FY 2023 and 16.3 cents per share in FY 2024. Based on the current Medibank share price of $3.47, this will mean yields of 4.6% and 4.7%, respectively.

The post Boost your income with these ASX dividend shares: experts appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• What is the outlook for the Medibank dividend in FY23?
• The biggest threats and opportunities for ASX industrial REITs revealed: fund manager
• How this ASX 200 REIT is delivering 5% plus dividend yields: fund manager
• What’s the outlook for the Medibank share price in FY23?
• ‘Sweet spot’: Citi names 2 ASX 200 shares that are ‘inexpensive’ right now

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/iO7BZVe